Capricor Therapeutics (CAPR) Share-based Compensation Growth (1y) (2011 - 2026)
Capricor Therapeutics (CAPR) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
-69.95% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
0.18% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Capricor Therapeutics |
1.53 Bn |
1.26 Bn |
- |
2,198.62% |
| Date | Value |
|---|
| Mar 31, 2026 |
2,198.62% |
| Dec 31, 2025 |
67.33% |
| Sep 30, 2025 |
94.87% |
| Jun 30, 2025 |
312.10% |
| Mar 31, 2025 |
-92.12% |
| Dec 31, 2024 |
23.31% |
| Sep 30, 2024 |
19.46% |
| Jun 30, 2024 |
32.99% |
| Mar 31, 2024 |
48.78% |
| Dec 31, 2023 |
62.14% |
| Sep 30, 2023 |
57.96% |
| Jun 30, 2023 |
39.80% |
| Mar 31, 2023 |
106.02% |
| Dec 31, 2022 |
47.18% |
| Sep 30, 2022 |
50.93% |
| Jun 30, 2022 |
62.56% |
| Mar 31, 2022 |
41.49% |
| Dec 31, 2021 |
64.68% |
| Sep 30, 2021 |
47.97% |
| Jun 30, 2021 |
1.13% |
